Chapter 10 Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease

Progress in Brain Research

Volumn 158, Issue , 2006, Pages 197-222

  Mufson, Elliott J ^a   Counts, Scott E ^a   Che, Shaoli ^b,c   Ginsberg, Stephen D ^b,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Nathan Kline Institute   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; Alzheimer's disease; microarray; Parkinson's disease; RNA amplification; schizophrenia

Indexed keywords

ANIMAL; BRAIN; DEGENERATIVE DISEASE; DNA FINGERPRINTING; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METHODOLOGY; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; DNA FINGERPRINTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33749237719     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)58010-0     Document Type: Review

References (141)

1. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., and Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69 (1997) 1196-1203
2. Amaral, D.G. (1987) Memory: anatomical organization of candidate brain regions. In: Mountcastle, V.B., Plum, F. and Geiger, S.R. (Eds.), Handbook of Physiology. Section 1: The Nervous System. V. Higher Functions of the Brain, Part 1. American Physiological Society, Bethesda, MD, pp. 211-294.
3. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., and Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry 55 (1998) 225-232
4. Baranzini S.E. Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain. Neuromol. Med. 6 (2004) 31-51
5. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163 (2000) 495-529
6. Baxter M.G., and Chiba A.A. Cognitive functions of the basal forebrain. Curr. Opin. Neurobiol. 9 (1999) 178-183
7. Becker K.G., Mattson D.H., Powers J.M., Gado A.M., and Biddison W.E. Analysis of a sequenced cDNA library from multiple sclerosis lesions. J. Neuroimmunol. 77 (1997) 27-38
8. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., and Bach J. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
9. Berchtold N.C., and Cotman C.W. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol. Aging 19 (1998) 173-189
10. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
11. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., and Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64 (1995) 749-760
12. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 101 (2004) 2173-2178
13. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
14. Brady D.R., and Mufson E.J. Amygdaloid pathology in Alzheimer's disease: a qualitative and quantitative analysis. Dementia 1 (1990) 5-17
15. Callahan L.M., and Coleman P.D. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging 16 (1995) 311-314
16. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., Lippa C., and Nixon R.A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14 (1995) 671-680
17. Cataldo A.M., Hamilton D.J., Barnett J.L., Paskevich P.A., and Nixon R.A. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16 (1996) 186-199
18. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
19. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273 (1988) 543-557
20. Cheetham J.E., Coleman P.D., and Chow N. Isolation of single immunohistochemically identified whole neuronal cell bodies from post-mortem human brain for simultaneous analysis of multiple gene expression. J. Neurosci. Methods 77 (1997) 43-48
21. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., and Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279 (2004) 13256-13264
22. Chow N., Cox C., Callahan L.M., Weimer J.M., Guo L., and Coleman P.D. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 95 (1998) 9620-9625
23. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002) 462-473
24. Colantuoni C., Purcell A.E., Bouton C.M., and Pevsner J. High throughput analysis of gene expression in the human brain. J. Neurosci. Res. 59 (2000) 1-10
25. Compston A. The epidemiology of multiple sclerosis: principles, achievements, and recommendations. Ann. Neurol. 36 2 (1994) S211-S217
26. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., and Lansbury Jr. P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 571-576
27. Conway K.A., Rochet J.C., Bieganski R.M., and Lansbury Jr. P.T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294 (2001) 1346-1349
28. Counts S.E., Chen E.Y., Che S., Ikonomovic M.D., Wuu J., Ginsberg S.D., DeKosky S.T., and Mufson E.J. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21 (2006) 205-214
29. Counts S.E., He B., Che S., Ginsberg S.D., and Mufson E.J. cDNA array analysis of galanin-hyperinnervated cholinergic basal forebrain neurons in Alzheimer's disease. Soc. Neurosci. 80 (2005) 12 Washington, DC
30. Counts S.E., Perez S.E., Ginsberg S.D., De Lacalle S., and Mufson E.J. Galanin in Alzheimer disease. Mol. Interv. 3 (2003) 137-156
31. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171 (1979) 319-327
32. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2 (1976) 1403
33. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990) 457-464
34. Ding X., Mactavish D., Kar S., and Jhamandas J.H. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol. Dis 21 (2005) 413-420
35. Dragoi G., Harris K.D., and Buzsaki G. Place representation within hippocampal networks is modified by long-term potentiation. Neuron 39 (2003) 843-853
36. Dunckley, T., Beach, T.G., Ramsey, K.E., Grover, A., Mastroeni, D., Walker, D.G., LaFleur, B.J., Coon, K.D., Brown, K.M., Caselli, R., Kukull, W.A., Higdon, R., McKeel, D., Morris, J.C., Hulette, C., Schmechel, D., Reiman, E.M., Rogers, J. and Stephan, D.A. (2006). Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging, in press.
37. Eberwine J., Yeh H., Miyashiro K., Cao Y., Nair S., Finnell R., Zettel M., and Coleman P. Analysis of gene expression in single live neurons. Proc. Natl. Acad. Sci. USA 89 (1992) 3010-3014
38. Eikelenboom P., and Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 17 (1996) 673-680
39. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., and Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons higher than previously reported. JAMA 262 (1989) 2551-2556
40. Fasulo W.H., and Hemby S.E. Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J. Neurochem. 87 (2003) 205-219
41. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
42. Ginsberg S.D. RNA amplification strategies for small sample populations. Methods 37 (2005) 229-237
43. Ginsberg S.D., and Che S. RNA amplification in brain tissues. Neurochem. Res. 27 (2002) 981-992
44. Ginsberg S.D., and Che S. Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus. Lab. Invest. 84 (2004) 952-962
45. Ginsberg S.D., and Che S. Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons. J. Comp. Neurol. 487 (2005) 107-118
46. Ginsberg S.D., Che S., Counts S.E., and Mufson E.J. Shift in the ratio of 3-repeat tau and 4-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J. Neurochem. 96 (2006) 1401-1408
47. Ginsberg S.D., Che S., Wuu J., Counts S.E., and Mufson E.J. Down-regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J. Neurochem. 97 (2006) 475-487
48. Ginsberg S.D., Crino P.B., Hemby S.E., Weingarten J.A., Lee V.M.-Y., Eberwine J.H., and Trojanowski J.Q. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45 (1999) 174-181
49. Ginsberg S.D., Crino P.B., Lee V.M.-Y., Eberwine J.H., and Trojanowski J.Q. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann. Neurol. 41 (1997) 200-209
50. Ginsberg S.D., Elarova I., Ruben M., Tan F., Counts S.E., Eberwine J.H., Trojanowski J.Q., Hemby S.E., Mufson E.J., and Che S. Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem. Res. 29 (2004) 1053-1064
51. Ginsberg S.D., Galvin J.E., Chiu T.S., Lee V.M.-Y., Masliah E., and Trojanowski J.Q. RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol. (Berl.) 96 (1998) 487-494
52. Ginsberg S.D., Hemby S.E., Lee V.M.-Y., Eberwine J.H., and Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48 (2000) 77-87
53. Ginsberg S.D., Schmidt M.L., Crino P.B., Eberwine J.H., Lee V.M.-Y., and Trojanowski J.Q. Molecular pathology of Alzheimer's disease and related disorders. In: Peters A., and Morrison J.H. (Eds). Neurodegenerative and Age-related Changes in Structure and Function of Cerebral Cortex (1999), Kluwer, New York 603-653
54. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
55. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., and Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8 (1989) 393-399
56. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13 (2003) 554-573
57. Greengard P., Valtorta F., Czernik A.J., and Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259 (1993) 780-785
58. Griffin W.S., Ling C., White III C.L., and Morrison-Bogorad M. Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 4 (1990) 69-78
59. Grunblatt E., Mandel S., Jacob-Hirsch J., Zeligson S., Amariglo N., Rechavi G., Li J., Ravid R., Roggendorf W., Riederer P., and Youdim M.B. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J. Neural Transm. 111 (2004) 1543-1573
60. Gur R.C., and Gur R.E. Neuroimaging applications in elderly patients. Am. J. Geriatr. Psychiatry 10 (2002) 5-11
61. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., and Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98 (2001) 4746-4751
62. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997) 154-159
63. Harrison P.J., Barton A.J., Najlerahim A., McDonald B., and Pearson R.C. Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease. Psychol. Med. 21 (1991) 855-866
64. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., and Hirsch E.C. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA 97 (2000) 2875-2880
65. Hartmann A., Michel P.P., Troadec J.D., Mouatt-Prigent A., Faucheux B.A., Ruberg M., Agid Y., and Hirsch E.C. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?. J. Neurochem. 76 (2001) 1785-1793
66. Hartmann A., Mouatt-Prigent A., Vila M., Abbas N., Perier C., Faucheux B.A., Vyas S., and Hirsch E.C. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease. Neurobiol. Dis. 10 (2002) 28-32
67. Hauser M.A., Li Y.J., Xu H., Noureddine M.A., Shao Y.S., Gullans S.R., Scherzer C.R., Jensen R.V., McLaurin A.C., Gibson J.R., Scott B.L., Jewett R.M., Stenger J.E., Schmechel D.E., Hulette C.M., and Vance J.M. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch. Neurol. 62 (2005) 917-921
68. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., and Eberwine J.H. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry 59 (2002) 631-640
69. Henke H., and Lang W. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267 (1983) 281-291
70. Hill W.D. Altered neurofilament expression does not contribute to Lewy body formation. Am. J. Pathol. 149 (1996) 728-729
71. Ho L., Guo Y., Spielman L., Petrescu O., Haroutunian V., Purohit D., Czernik A., Yemul S., Aisen P.S., Mohs R., and Pasinetti G.M. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci. Lett. 298 (2001) 191-194
72. Hof P.R., Giannakopoulos P., Vickers J.C., Bouras C., and Morrison J.H. The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype. Rev. Neurosci. 6 (1995) 97-124
73. Hyman B.T., Van Hoesen G.W., and Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 40 (1990) 1721-1730
74. Hyman B.T., Van Hoesen G.W., Damasio A.R., and Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225 (1984) 1168-1170
75. Hyman B.T., Van Hoesen G.W., Kromer L.J., and Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20 (1986) 472-481
76. Itagaki S., McGeer P.L., Akiyama H., Zhu S., and Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24 (1989) 173-182
77. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57 (2005) 236-251
78. Johns L.C., and van Os J. The continuity of psychotic experiences in the general population. Clin. Psychol. Rev. 21 (2001) 1125-1141
79. Joyce J.N., Kaeger C., Ryoo H., and Goldsmith S. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci. Lett. 154 (1993) 171-174
80. Kamme F., Salunga R., Yu J., Tran D.T., Zhu J., Luo L., Bittner A., Guo H.Q., Miller N., Wan J., and Erlander M. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J. Neurosci. 23 (2003) 3607-3615
81. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10 (2000) 381-391
82. Kurtz M.M., Moberg P.J., Gur R.C., and Gur R.E. Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol. Rev. 11 (2001) 197-210
83. Lad S.P., Neet K.E., and Mufson E.J. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr. Drug Target CNS Neurol. Disord. 2 (2003) 315-334
84. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12
85. Lencz T., Cornblatt B., and Bilder R.M. Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. Psychopharmacol. Bull. 35 (2001) 95-125
86. Lewis D.A. In pursuit of the pathogenesis and pathophysiology of schizophrenia: where do we stand?. Am. J. Psychiatry 159 (2002) 1467-1469
87. Lindberg R.L., De Groot C.J., Certa U., Ravid R., Hoffmann F., Kappos L., and Leppert D. Multiple sclerosis as a generalized CNS disease - comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J. Neuroimmunol. 152 (2004) 154-167
88. Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22 (2005) 1942-1950
89. Liu Y., Fallon L., Lashuel H.A., Liu Z., and Lansbury Jr. P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111 (2002) 209-218
90. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
91. Lombardino A.J., Li X.C., Hertel M., and Nottebohm F. Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels. Proc. Natl. Acad. Sci. USA 102 (2005) 8036-8041
92. Loring J.F., Wen X., Lee J.M., Seilhamer J., and Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20 (2001) 683-695
93. Lu L., Neff F., Alvarez-Fischer D., Henze C., Xie Y., Oertel W.H., Schlegel J., and Hartmann A. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease. Exp. Neurol. 195 (2005) 27-39
94. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., and Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 429 (2004) 883-891
95. Lukiw W.J. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29 (2004) 1287-1297
96. Luo L.G., and Jackson I.M. Advantage of double labeled in situ hybridization for detecting the effects of glucocorticoids on the mRNAs of protooncogenes and neural peptides (TRH) in cultured hypothalamic neurons. Brain Res. Brain Res. Protoc. 4 (1999) 201-208
97. Malaspina A., Kaushik N., and de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77 (2001) 132-145
98. Malinow R., Mainen Z.F., and Hayashi Y. LTP mechanisms: from silence to four-lane traffic. Curr. Opin. Neurobiol. 10 (2000) 352-357
99. Martin L.J., Price A.C., Kaiser A., Shaikh A.Y., and Liu Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death. Int. J. Mol. Med. 5 (2000) 3-13
100. McCormick D.A., and Contreras D. On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 63 (2001) 815-846
101. Merrick S.E., Trojanowski J.Q., and Lee V.M.-Y. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17 (1997) 5726-5737
102. Mesulam M.M., Mufson E.J., Levey A.I., and Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214 (1983) 170-197
103. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., and Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22 (2002) 2718-2729
104. Mimmack M.L., Ryan M., Baba H., Navarro-Ruiz J., Iritani S., Faull R.L., McKenna P.J., Jones P.B., Arai H., Starkey M., Emson P.C., and Bahn S. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99 (2002) 4680-4685
105. Morrison J.H., and Hof P.R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog. Brain Res. 136 (2002) 467-486
106. Mufson E.J., Bothwell M., and Kordower J.H. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105 (1989) 221-232
107. Mufson E.J., Cochran E., Benzing W., and Kordower J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4 (1993) 237-250
108. Mufson E.J., Counts S.E., and Ginsberg S.D. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27 (2002) 1035-1048
109. Mufson E.J., Ikonomovic M.D., Styren S.D., Counts S.E., Wuu J., Leurgans S., Bennett D.A., Cochran E.J., and DeKosky S.T. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch. Neurol. 60 (2003) 1143-1148
110. Mycko M.P., Papoian R., Boschert U., Raine C.S., and Selmaj K.W. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126 (2003) 1048-1057
111. Nagasaka Y., Dillner K., Ebise H., Teramoto R., Nakagawa H., Lilius L., Axelman K., Forsell C., Ito A., Winblad B., Kimura T., and Graff C. A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc. Natl. Acad. Sci. USA 102 (2005) 14854-14859
112. Nixon R.A., Cataldo A.M., and Mathews P.M. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25 (2000) 1161-1172
113. Perry E.K., Gibson P.H., Blessed G., Perry R.H., and Tomlinson B.E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34 (1977) 247-265
114. Pongrac J., Middleton F.A., Lewis D.A., Levitt P., and Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem. Res. 27 (2002) 1049-1063
115. Prentice, T. (2001). The World Health Reoprt 2001. Mental health: new understanding, new hope. World Health Organization, Geneva.
116. Prusiner S.B. The prion diseases. Brain Pathol. 8 (1998) 499-513
117. Ramanathan M., Weinstock-Guttman B., Nguyen L.T., Badgett D., Miller C., Patrick K., Brownscheidle C., and Jacobs L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116 (2001) 213-219
118. Rosene D.L., and Van Hoesen G.W. The hippocampal formation in the primate brain. A review of some comparative aspects of cytoarchitecture and connections. In: Jones E.G., and Peters A. (Eds). Cerebral Cortex Vol. 6 (1987), Plenum, New York 345-455
119. Ryoo H.L., and Joyce J.N. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J. Comp. Neurol. 348 (1994) 94-110
120. Salehi A., Verhaagen J., Dijkhuizen P.A., and Swaab D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75 (1996) 373-387
121. Sarnat H.B., Curry B., Rewcastle N.B., and Trevenen C.L. Gliosis and glioma distinguished by acridine orange. Can. J. Neurol. Sci. 14 (1987) 31-35
122. Sassin I., Schultz C., Thal D.R., Rub U., Arai K., Braak E., and Braak H. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. (Berl.) 100 (2000) 259-269
123. Scheff S.W., and Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 24 (2003) 1029-1046
124. Scheff, S.W., Price, D.A., Schmitt, F.A. and Mufson, E.J. (2006). Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging, in press.
125. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275 (1997) 630-631
126. Serafini T. Of neurons and gene chips. Curr. Opin. Neurobiol. 9 (1999) 641-644
127. Sherer T.B., Betarbet R., Stout A.K., Lund S., Baptista M., Panov A.V., Cookson M.R., and Greenamyre J.T. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22 (2002) 7006-7015
128. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
129. Sorensen J.B. SNARE complexes prepare for membrane fusion. Trends Neurosci. 28 (2005) 453-455
130. Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
131. Tang W.X., Fasulo W.H., Mash D.C., and Hemby S.E. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J. Neurochem. 85 (2003) 911-924
132. Teng K.K., and Hempstead B.L. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol. Life Sci. 61 (2004) 35-48
133. Trojanowski J.Q., and Arnold S.E. In pursuit of the molecular neuropathology of schizophrenia. Arch. Gen. Psychiatry 52 (1995) 274-276
134. Trojanowski J.Q., and Lee V.M. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55 (1998) 151-152
135. Vogt L.J., Nimchinsky E.A., and Hof P.R. Primate cingulate cortex chemoarchitecture and it's disruption in Alzheimer's disease. In: Bloom F., Bjorklund A., and Hokfelt T. (Eds). The Primate Nervous System, Part I Vol. 13 (1997), Elsevier, Amsterdam 455-528
136. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., and DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10 (1981) 122-126
137. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
138. Whitney L.W., Becker K.G., Tresser N.J., Caballero-Ramos C.I., Munson P.J., Prabhu V.V., Trent J.M., McFarland H.F., and Biddison W.E. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46 (1999) 425-428
139. Xiang W., Windl O., Westner I.M., Neumann M., Zerr I., Lederer R.M., and Kretzschmar H.A. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 58 (2005) 242-257
140. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., and Coleman P.D. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12 (2003) 97-109
141. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., and Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154 (1999) 1423-1429